drugset / Trial / NCT00266721

Efficacy of Pancrelipase on Postprandial Belching and Bloating.

NCT00266721 ↗

Phase 3 Completed 45 enrolled Solvay Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.

Timeline

Start
2000-01
Primary completion
—
Completion
2000-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pancrelipase Protein / enzyme biologic — —

Indications